title: Reexamination of dopamine as the prolactin-release inhibiting factor (PIF): supplementary agent may be required for dopamine to function as the physiological PIF.
abstract: A large number of studies have been performed concerning dopamine's inhibitory effect on prolactin release, but many of these studies have examined the effect of dopamine dissolved in a solution containing ascorbic acid. Ascorbic acid, routinely used to protect dopamine from oxidation, alone does not stimulate or inhibit prolactin release, but it can potentiate the inhibitory effect of dopamine in a static monolayer culture system by approximately 100 times. We have closely examined the inhibitory effect of dopamine on prolactin release in the absence of ascorbic acid using a perifusion system. Male rat adenohypophyses were dispersed with trypsin and cultured in a Petri dish to form cell clusters. Inhibition of prolactin release by dopamine (1 mumol/L) in the absence of ascorbic acid was sustained for only 63 min during the 2-h perifusion period. Following a 2-h period of incubation of dopamine in the same experimental solution, the dopamine concentration was reduced from 1 to 0.18 mumol/L, yet this "2-h-old dopamine" was still effective in inhibiting prolactin release (approximately 30 min). This result suggests that the lactotrophs may be desensitized by chronic exposure to a high concentration of dopamine in the absence of ascorbic acid. In contrast, when a low concentration of dopamine (3 nmol/L) containing ascorbic acid (0.1 mmol/L) was perifused, inhibition of prolactin release was sustained for the entire 2-h perifusion period. Although there may be a large number of explanations for dopamine's transient inhibitory effect on prolactin release, the present results suggest that dopamine may require supplementary agent(s) to effectively inhibit prolactin release and thus function as the prolactin release inhibitory factor (PIF).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Physiology, Queen's University, Kingston, Ont., Canada.
authors.forename: S H
authors.initials: SH
authors.lastname: Shin
authors.forename: S F
authors.initials: SF
authors.lastname: Hanna
authors.forename: M
authors.initials: M
authors.lastname: Hong
authors.forename: K
authors.initials: K
authors.lastname: Jhamandas
mesh_terms: D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology* / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D007700:Kinetics; D008297:Male; D011388:Prolactin / Q000378:metabolism; D011389:Prolactin Release-Inhibiting Factors / Q000502:physiology*; D051381:Rats; D011919:Rats, Inbred Strains; D013004:Somatostatin / Q000494:pharmacology / Q000502:physiology; D013997:Time Factors
chemical_list: D013004:Somatostatin; D011388:Prolactin; D011389:Prolactin Release-Inhibiting Factors; D001205:Ascorbic Acid; D004298:Dopamine